NovaBay Pharmaceuticals, Inc.
(NYSE Amex Equities : NBY)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 15.38%125.970.0%$1974.24m
BIIBBiogen, Inc. 0.67%243.361.7%$667.62m
AMGNAmgen, Inc. 2.51%225.831.3%$584.32m
GILDGilead Sciences, Inc. 0.50%59.801.0%$532.26m
VRTXVertex Pharmaceuticals, Inc. 3.72%226.221.9%$487.10m
REGNRegeneron Pharmaceuticals, Inc. 1.40%515.412.7%$475.99m
BNTXBioNTech SE 3.67%108.820.0%$471.18m
NVAXNovavax, Inc. 20.86%124.0092.9%$450.15m
ILMNIllumina, Inc. 4.87%318.793.5%$399.74m
MGENMiragen Therapeutics, Inc. 3.64%16.800.7%$276.81m
APVOAptevo Therapeutics, Inc. 0.07%43.8418.3%$230.72m
EXASEXACT Sciences Corp. 2.58%118.8619.6%$201.83m
SGENSeagen Inc. 2.09%168.905.8%$181.80m
SRRKScholar Rock Holding Corp. 4.69%46.800.0%$173.30m
ALXNAlexion Pharmaceuticals, Inc. 0.68%123.762.0%$165.78m

Company Profile

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing products for the eye care market. Its products include Avenova, NeutroPhase, and CelleRx. The company was founded by Ramin Najafi on January 19, 2000 and is headquartered in Emeryville, CA.